A dose by any other name would not sell as sweet

Inventors of drug names suddenly stood the alphabet on its head. Why did z and x become so attractive in the attempt to influence prescribers? asks Rob Stepney

If you leaf through the June 2000 issue of the British Journal of Cardiology you will see advertisements for Zocor, Xenical, and Cozaar before you reach a brand name that does not contain a prominent x or z (and that brand is Viagra). In an issue of Hospital Doctor from the same month (22 June), adverts for Celebrex, Topamax, Flomax, Vioxx, Zispin, Zyprexa, Oxis, Efexor, and Fosamax outnumber those for brands not containing letters from the tail end of the alphabet. Examination of the British National Formulary (BNF) from 1986 to 2004 confirms that z and x suddenly achieved remarkable and previously unexplained popularity in the branding of drugs.

=> http://bit.ly/hrz1Z1

4 replies
  1. Terri
    Terri says:

    Hello, I think your blog might be having browser compatibility issues.
    When I look at your blog site in Firefox, it looks fine but
    when opening in Internet Explorer, it has some overlapping.
    I just wanted to give you a quick heads up! Other then
    that, very good blog!

    • admin
      admin says:

      Thanks. I have opened the blog in Internet explorer and cannot see any problems. Could you explain exactly what they are please.

    • admin
      admin says:

      Thanks for pointing this out. It was an article on the letters used in the names of drugs. Perhaps the browser thinks it is trying to sell drugs. Perhaps I had better remove it. Shame!

Comments are closed.